| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/19/2006 | WO2006007557A2 Ryegrass cbf3 gene : identification and isolation |
| 01/19/2006 | WO2006007539A1 Vector packaging cell line |
| 01/19/2006 | WO2006007515A2 Functional assessment, specific enrichment and specific depletion of alloreactive human t cells |
| 01/19/2006 | WO2006007514A2 Methods for producing functional antigen presenting dentritic cells using biodegradable microparticles for delivery of antigenic materials |
| 01/19/2006 | WO2006007377A2 Methods of screening for bridge-1-mediated disorders, including type ii diabetes |
| 01/19/2006 | WO2006007375A2 Use of bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes |
| 01/19/2006 | WO2006007202A2 Canine cd20 compositions |
| 01/19/2006 | WO2006006722A1 Method of controlling cell functions |
| 01/19/2006 | WO2006006720A1 METHOD OF CULTURING ϜδT CELLS, ϜδT CELLS AND REMEDY/PREVENTIVE |
| 01/19/2006 | WO2006006710A1 Polypeptide having δ5 fatty acid unsaturating activity, polynucleotide coding for the polypeptide, and use thereof |
| 01/19/2006 | WO2006006692A1 Animal tissue-eccentrically located pluripotent cell proliferating selectively in low-serium medium |
| 01/19/2006 | WO2006006638A1 DENDRITIC CELL, DRUG CONTAINING THE DENDRITIC CELL, THERAPEUTIC METHOD USING THE DENDRITIC CELL AND METHOD OF CULTURING ϜδT CELL |
| 01/19/2006 | WO2006006273A1 Dendritic cell activator |
| 01/19/2006 | WO2006006171A2 Expansion of stem/progenitor cells by inhibition of enzymatic reactions catalyzed by the sir2 family of enzymes |
| 01/19/2006 | WO2006005977A1 Novel method for culturing keratinocytes, melanocytes and fibroblasts for skin grafting |
| 01/19/2006 | WO2006005887A1 Method for localizing a chemical or biological species on a substrate, analyzing microsystem and biochip |
| 01/19/2006 | WO2006005802A1 Method for stimulating mammalian cells and mammalian cell |
| 01/19/2006 | WO2006005360A1 Devices and methods for growing human cells |
| 01/19/2006 | WO2006005153A1 Nup98-hox fusions for expansion of hemopoietic stem cells |
| 01/19/2006 | WO2005107807A3 Cerebral intraventricular transplantation as method of treating amyotrophic lateral sclerosis |
| 01/19/2006 | WO2005100564A3 Intervention in the energy metabolism of eukaryote cells for the purposes of selection and increased expression |
| 01/19/2006 | WO2005094324A3 Mixed cell diagnostic systems |
| 01/19/2006 | WO2005089285A3 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
| 01/19/2006 | WO2005017149A8 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 01/19/2006 | WO2004072226A3 Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells |
| 01/19/2006 | US20060015972 Plant transcriptional regulators of drought stress |
| 01/19/2006 | US20060015970 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 01/19/2006 | US20060015969 Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases |
| 01/19/2006 | US20060015968 Nucleotide sequences mediating male fertility and method of using same |
| 01/19/2006 | US20060015966 Transgenic plant cells and plants having modified activity of the GBSSI and of the BE protein |
| 01/19/2006 | US20060015962 Soybean cultivar 1000109 |
| 01/19/2006 | US20060015961 Methods and compositions for producing germ cells from peripheral blood derived germline stem cells |
| 01/19/2006 | US20060015959 Transgenic animals expressing transglutaminase II |
| 01/19/2006 | US20060015958 Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission |
| 01/19/2006 | US20060015951 Proteins involved in the regulation of energy homeostasis |
| 01/19/2006 | US20060015949 Transgenic non-human animals for producing heterologous and chimeric antibodies |
| 01/19/2006 | US20060014936 Hybrid bacillus thuringiensis Cry1A/Cry1F DNA and plants and host cells transformed with same |
| 01/19/2006 | US20060014932 Purified and isolated protein zero related (PZR) and therapeutic and screening methods using same |
| 01/19/2006 | US20060014931 Novel promoter |
| 01/19/2006 | US20060014715 Control of gene expression |
| 01/19/2006 | US20060014682 Chemokine receptor antagonist peptide with a sequence homologous to SDF-1 wherein at least one amino acid at positions five to eight are substituted with proline; proliferative agents; self-regeneration of stem cells |
| 01/19/2006 | US20060014288 Nerve regeneration |
| 01/19/2006 | US20060014287 Propagating myogenic progenitor cells for use in treatment of muscle disorders; tissue repair; tissue targeted therapy |
| 01/19/2006 | US20060014284 Biomatrix and method for producting the same |
| 01/19/2006 | US20060014283 inorganic bone graft materials and a method for preparing the bone graft materials. Particularly, the present invention relates to a method for preparing bone graft materials comprises the following steps: collecting cancellous bones from an animal; removing lipids and organic materials from the bones |
| 01/19/2006 | US20060014282 Cell and tissue engineering utilizing LIF |
| 01/19/2006 | US20060014281 Neural stem cells |
| 01/19/2006 | US20060014280 Culturing differentiating pluripotent human cell with N-palmitoyl serinol or N-oleoyl serinol in serum-free medium; modulating apoptosis |
| 01/19/2006 | US20060014279 culturing human embryonic stem cells in a medium including salts, vitamins, amino acids, glucose, fibroblast growth factors and a bone morphogenic protein antagonist in sufficient amount to maintain the stem cells in an undifferentiated state |
| 01/19/2006 | US20060014278 Method for programmed differentiation of stem cells |
| 01/19/2006 | US20060014277 Novel human kielin-like proteins and polynucleotides encoding the same |
| 01/19/2006 | US20060014276 Chimeric adenoviruses |
| 01/19/2006 | US20060014249 Human G-protein coupled receptor |
| 01/19/2006 | US20060014245 Immunotoxins containing a cytotoxic RNAse fused to the N-terminus of one antibody variable domain prepared and retain the ability to specifically bind antigen; cancer |
| 01/19/2006 | US20060014243 Human G-protein chemokine receptor HSATU68 |
| 01/19/2006 | US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 01/19/2006 | US20060014222 Antibodies |
| 01/19/2006 | US20060014219 Method for measuring ion channel activity |
| 01/19/2006 | US20060014188 System to detect inducible translocation |
| 01/19/2006 | US20060014180 Human phosphatase RET31, and variants thereof |
| 01/19/2006 | US20060014148 Igg fc/hiv-gp120/c3d fusion protien |
| 01/19/2006 | US20060014143 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 01/19/2006 | US20060014139 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 01/19/2006 | US20060013832 Methods for treating HIV infected subjects |
| 01/19/2006 | US20060013824 RSV proteins, antibodies, compositions, methods and uses |
| 01/19/2006 | US20060013817 identification of genetic products that are expressed in association with a tumor and the nucleic acid coding therefor. The invention relates to the therapy and diagnosis of diseases in which said genetic products that are expressed in association with a tumor are expressed in an aberrant manner. |
| 01/19/2006 | US20060013805 Transgenic circulating endothelial cells |
| 01/19/2006 | US20060013804 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 01/19/2006 | US20060013803 Modified dendritic cells |
| 01/19/2006 | CA2573176A1 Nup98-hox fusions for expansion of hemopoietic stem cells |
| 01/19/2006 | CA2572881A1 Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication |
| 01/19/2006 | CA2572467A1 Vector packaging cell line |
| 01/19/2006 | CA2572065A1 Immunosuppressive exosomes |
| 01/19/2006 | CA2570298A1 Polynucleotides encoding mature ahasl proteins for creating imidazolinone-tolerant plants |
| 01/19/2006 | CA2475174A1 Isolated muscle satellite cells, use thereof in muscle tissue repair and method for isolating said muscle satellite cells |
| 01/18/2006 | EP1616961A1 Vectors and methods for gene transfer to cells |
| 01/18/2006 | EP1616960A2 Human pancreatic cell lines: developments and uses |
| 01/18/2006 | EP1616958A2 Notch-ligands for use in immunotherapy |
| 01/18/2006 | EP1616944A1 Method of growing sperm stem cells in vitro, sperm stem cells grown by the method, and medium additive kit to be used in growing sperm stem cells in vitro |
| 01/18/2006 | EP1616943A1 Avian primordial germ cell (PGC) cell line and a method for long term culturing thereof |
| 01/18/2006 | EP1616942A2 Patched genes and their use |
| 01/18/2006 | EP1616941A1 Method of producing lens cell and lens cell obtained by the method |
| 01/18/2006 | EP1616939A1 Cell culture medium and solidified preparation of cell adhesion protein or peptide |
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616882A2 Apo-2 receptor antibodies |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616579A1 CD40 binding molecules and CTL peptides for treating tumors |
| 01/18/2006 | EP1616183A2 Methods of detecting neurological disorders |
| 01/18/2006 | EP1616002A2 Method for obtaining mastocyte lines from porcine tissue and method for production of heparin type molecules |
| 01/18/2006 | EP1616001A1 Method for improving germline transmission efficiency of avian primordial germ cells |
| 01/18/2006 | EP1616000A1 Expression of proteins in cord blood-derived endothelial cells |
| 01/18/2006 | EP1615999A2 Novel process for detaching confluent cells from two dimensional microsupports and its application for preparing transplants |
| 01/18/2006 | EP1615997A2 Methods for neural differentiation of embryonic stem cells using protease passaging techniques |
| 01/18/2006 | EP1615996A2 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip) |
| 01/18/2006 | EP1615995A2 Morpholino imaging and therapy via amplification targeting |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1615946A2 Proteolytic and covalent antibodies |
| 01/18/2006 | EP1615676A2 Porous particulate collagen sponges |
| 01/18/2006 | EP1615497A2 Methods of promoting cell viability |
| 01/18/2006 | EP1487968A4 Methods of inducing differentiation of stem cells into a specific cell lineage |